Literature DB >> 7479676

The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation.

A Borgström1, J Axelson, I Ihse, J F Rehfeld.   

Abstract

The effects of long-term hyperstimulation with cholecystokinin (CCK) on the pancreatic contents of anionic and cationic trypsin(ogen) and amylase were studied in the rat. Endogenous hyperCCKemia was evoked in rats by pancreaticobiliary diversion (PBD), and exogenous hyperCCKemia by continuous subcutaneous CCK infusion. In addition, the effect of continuous subcutaneous infusion of the CCK A receptor antagonist devazepide was studied. After 4 weeks blood samples were obtained for the determination of plasma CCK concentrations and the animals were sacrificed. The pancreatic glands were harvested, weighted, and extracted. The extracts were analyzed for anionic and cationic trypsin and amylase. Enzyme contents showed a large interindividual variation. The most consistent change in enzyme pattern was an increase in the ratio between anionic and cationic trypsin in animals with hyperCCKemia (PBD operated or CCK infused). Furthermore, this ratio decreased significantly in animals treated with devazepide. In conclusion, stimulation of the CCK receptor changed the ratio between anionic and cationic trypsin in the pancreatic gland, while it was reversed during blockade of the receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479676     DOI: 10.1097/00006676-199508000-00011

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  2 in total

1.  Stimulation with cholecystokinin leads to increased ratio between mRNA levels for anionic and cationic trypsinogen in rat pancreas.

Authors:  A Borgström; X He; J Axelson
Journal:  J Gastroenterol       Date:  1997-12       Impact factor: 7.527

2.  Elevated serum levels of immunoreactive anionic trypsin (but not cationic trypsin) signals pancreatic disease.

Authors:  A Borgström; A Andrén-Sandberg
Journal:  Int J Pancreatol       Date:  1995-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.